RPL13AP5 (Gene)

Entrez:728658

Description:ribosomal protein L13a pseudogene 5

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View RPL13AP5's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with RPL13AP5.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using RPL13AP5.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for RPL13AP5.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with RPL13AP5.

Results found

Linked to

	Label	Description
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 5 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE210476 rutaecarpine macrophage 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 5 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE183741 GSE183806 POU2F2 POU2AF1 knockdown UtE-iPS-1 2 v 4 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 0 v 3 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE85880 GSE85881 tretinoin cardiac muscle cell 0 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE210476 rutaecarpine macrophage 2 v 7 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.